Company intelligence / Profile preview
Primera Therapeutics
Rockville, Maryland, United Statesprimeratherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Primera Therapeutics is developing a first-in-class, TALE-based gene editing platform to precisely correct mutations in mitochondrial DNA. The company is at the pre-clinical stage with its lead programs focused on rare inherited mitochondrial diseases for which there are currently no approved therapies. No clinical results have been reported yet as all programs remain in discovery or preclinical optimization.
- Therapeutic areas
- NephrologyRare Diseases
- Modalities
- Gene therapyTALE-based gene editing (Transcription Activator-Like Effector-based gene editing)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Cellectis (gene-editing technology collaboration)Mayo Clinic (scientific founder and research partner)United Mitochondrial Disease Foundation (UMDF)Children’s Hospital of Philadelphia/Mayo Clinic/CHOP
Beyond the preview
Go deeper on Primera Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Primera Therapeutics.